Russell Bagnall
About
Russell Bagnall has been a partner at Adams & Adams since 1998 and is head of the patent and design litigation group and was also the Patent Department’s chairman for a number of years. Before joining Adams & Adams, he spent several years employed by a multinational mining house. Russell specialises in patent litigation and opinion work, mainly in the fields of pharmaceuticals and chemistry.
He has advised clients on several contentious issues involving pharmaceutical disputes between multinational and generic companies. He also...
Read More- Patent, Copyright and Design Litigation
- Drafting of chemical, metallurgical and mineral processing related patent specifications
Academic Record
- BProc – University of South Africa | 1995
- BSc Eng (Metallurgy and Materials Minerals Process Engineering) – University of Witwatersrand | 1989
Qualifications
- Qualified Patent Attorney | 1997
- Admitted Attorney | 1997
Memberships
- Association for the Protection of Intellectual Property (AIPPI) – Member
- International Federation of Intellectual Property Attorneys (FICPI) – Member
- Legal Practice Council – Member
- Pretoria Attorneys Association (PAA) – Member
- South African Institute of Intellectual Property Law (SAIIPL) – Fellow
- Author: Getting the Deal Through – Patents – South African Chapter | 2013
- Listed in The Best Lawyers: South Africa in Intellectual Property Law (2020 – 2026)
- Chambers Global-Intellectual Property Patents: Ranked Band 1 | 2016 – 2026
- IAM Patent 1000 – Individuals: Patent Litigation | 2017 – 2025 (Gold)
- IFLR Patent Expert Guide – Experts for Patents | 2019
- Legal 500 – Recommended Lawyer: Intellectual Property | 2018 – 2026
- Managing IP – IP Star: Patents | 2014 – 2025
- Who’s Who Legal Ranking: Patents | 2016 – 2022
- Who’s Who Legal Ranking: Life Sciences | 2016 – 2017
- Who’s Who Legal: Thought Leaders Africa – Patents | 2024
- World IP Review – WIPR Leaders: Patents | 2018 – 2026
- WIPR – Trade Mark & Patent Directory | 2017
- Listed in IAM Global Leaders (2019 – 2026)
Closing the Peptide Gap: SAHPRA’s New Guideline on Synthetic Peptides
Weight-loss and diabetes medicines such as semaglutide have become some of the most sought-after medicines in the world. In South Africa, that demand has been met in part by large-scale compounding of...
October 19 2026
South African patent ruling in favour of Astellas Pharma
On 13 July 2026, the South African patent court ruled in favour of Astellas Pharma, the Japan-headquartered pharmaceutical company represented by intellectual property law firm Adams & Adams (Russ...
August 05 2026
Adams & Adams is a proud contributor to the chambers Life Sciences and Pharma IP litigation chapter
Life Sciences and Pharma IP Litigation 2025
March 04 2025

